BioCentury
ARTICLE | Clinical News

Luminate: Completed Phase IIb enrollment

October 10, 2016 7:00 AM UTC

Allegro completed enrollment of 100 patients in the double-blind, placebo-controlled, U.S. Phase IIb PACIFIC trial evaluating 1, 2, 3 and 4 mg intravitreal Luminate given on days 0, 30 and 60. Allegro...